T. Nevill

R. Larson, M. Slovak, F. Appelbaum, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intermittent Transfusion Independence Is Associated with Improved Overall Survival in Patients with Transfusion Dependent MDS

B. Leber, R. Wells, K. Yee, 2019, Blood.

Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real‐world outcomes from a population‐based cohort

A. Karsan, F. Kuchenbauer, M. Power, 2022, European journal of haematology.

Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome

T. Nevill, Luke Y. C. Chen, H. Cherniawsky, 2022, Canadian Medical Association Journal.

Development of a Biologically Distinct EBV-Related Lymphoproliferative Disorder Following Autologous Bone Marrow Transplantation for an EBV-Negative Post-Renal Allograft Burkitt's Lymphoma

R. Gascoyne, C. Lohrisch, P. Keown, 2000, Leukemia & lymphoma.

Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.

Matthew P Wright, M. Power, D. Hogge, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia.

S. Nantel, D. Forrest, K. Song, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection of MLL gene self-fusions by RT-PCR and automated fluorescent DNA-fragment analysis.

D. Horsman, T. Nevill, G. Growe, 1999, Cancer genetics and cytogenetics.

Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

M. Cazzola, H. Deeg, R. Schlenk, 2020, Leukemia.

VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome)

T. Nevill, Luke Y. C. Chen, Eric McGinnis, 2021, Haematologica.

Acute Myelogenous Leukemia Complicated by Acute Necrotizing Ulcerative Gingivitis Due to Aspergillus terreus

H. Khoury, C. Poh, T. Nevill, 2003, Leukemia & lymphoma.

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease

J. Lipton, S. Nantel, S. Nantel, 2005, Bone Marrow Transplantation.

Allografting for indolent lymphoid neoplasms.

D. Reece, J. Connors, S. Nantel, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.

J. Kuruvilla, D. Hogge, Clayton A. Smith, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry

B. Leber, R. Wells, D. Sutherland, 2018, European journal of haematology.

Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantation

J. Kuruvilla, D. Hogge, S. Nantel, 2004, Bone Marrow Transplantation.

Normal CD5+ B lymphocytes are poor stimulators in the autologous mixed lymphocyte reaction (AMLR)

T. Nevill, T. Nevill, L. Fernandez, 1997, Clinical and experimental immunology.

Apoptosis is the mode of keratinocyte death in cutaneous graft-versus-host disease.

R. Langley, N. Walsh, T. Nevill, 1996, Journal of the American Academy of Dermatology.

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens

D. Hogge, S. Nantel, D. Forrest, 2010, Bone Marrow Transplantation.

B. Leber, R. Wells, K. Yee, 2014 .

The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry

B. Leber, K. Yee, P. Spin, 2023, Leukemia & lymphoma.

Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin.

C. Currie, S. Nantel, C. Toze, 2000, Journal of hematotherapy & stem cell research.

Majocchi's granuloma in a patient with GATA2 haploinsufficiency undergoing hematopoietic stem cell transplantation

T. Nevill, V. Lavergne, S. Belga, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus.

B. Leber, J. Ashkenas, J. Brandwein, 2013, American journal of blood research.

Granulomatous Myositis as a Manifestation of Chronic Graft-Versus-Host Disease: A Case Series and Review of the Literature.

C. Toze, T. Nevill, Y. A. Mourad, 2022, Clinical lymphoma, myeloma & leukemia.

Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort

M. Power, R. Broady, D. Hogge, 2012 .

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)

J. Connors, M. Power, R. Broady, 2011, Leukemia & lymphoma.

Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20‐year cohort

J. Connors, M. Power, R. Broady, 2012, British journal of haematology.

Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia

D. Horsman, H. Bruyèrè, D. Hogge, 2006, Leukemia & lymphoma.

Allogeneic Stem Cell Transplant in First Complete Remission Overcomes the Poor Prognosis Associated with the FLT-3 Internal Tandem Duplication in Acute Myeloid Leukemia.

A. Brooks-Wilson, R. Brinkman, M. Power, 2007 .

Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signals.

H. Bruyèrè, S. Nantel, D. Forrest, 2013, Clinical lymphoma, myeloma & leukemia.

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes.

R. Gascoyne, J. Connors, D. Hogge, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an MDS‐CAN analysis

B. Leber, R. Wells, K. Yee, 2017, British journal of haematology.

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

T. Panzarella, G. Devins, Stephanie J. Lee, 2014 .

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.

T. Panzarella, G. Devins, Stephanie J. Lee, 2020, The Lancet. Haematology.

Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.

P. Lansdorp, D. Reece, K. Chan, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

J. Vose, J. Fay, S. Bhatia, 2003, Blood.

Excellent real‐world outcomes of adults with Burkitt lymphoma treated with CODOX‐M/IVAC plus or minus rituximab

L. Sehn, J. Connors, G. Slack, 2018, British journal of haematology.

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.

R. Gascoyne, L. Sehn, J. Connors, 2015, Clinical lymphoma, myeloma & leukemia.

High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.

D. Reece, N. Murray, S. Nantel, 1993, British Journal of Cancer.

Hematopoietic Stem Cell Transplant (HSCT) as Primary Treatment for T-Cell Lymphobastic Lymphoma (T-LBL) : An Intention to Treat Analysis.

R. Gascoyne, J. Connors, D. Hogge, 2004 .

The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.

P. Keown, K. Schultz, C. Toze, 1998, Transplantation proceedings.

Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center.

M. Power, R. Broady, D. Hogge, 2019, Clinical lymphoma, myeloma & leukemia.

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver.

R. Gascoyne, J. Connors, D. Reece, 2005, Blood.

Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.

D. Horsman, H. Bruyèrè, D. Hogge, 2006, Cancer genetics and cytogenetics.

High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.

R. Gascoyne, J. Connors, D. Hogge, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide.

D. Hogge, Clayton A. Smith, S. Nantel, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Reece, M. Barnett, H. Klingemann, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.

M. Power, Yunfeng Dai, D. Hogge, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.

M. Power, R. Broady, D. Hogge, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

B. Leber, K. Rockwood, R. Wells, 2016, British journal of haematology.

72 Allogeneic bone marrow transplantation for myelofibrosis due to agnogenic myeloid metaplasia (AMM) and essential thrombocytosis (ET): Experience of two bone marrow transplant centers

J. Lipton, D. Hogge, S. Nantel, 2003 .

Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.

D. Horsman, D. Hogge, Y. Chalandon, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome Of Patients With Double-Hit Lymphomas Treated With CODOX-M/IVAC + R Followed By Hematopoietic Stem Cell Transplantation In British Columbia

R. Gascoyne, L. Sehn, J. Connors, 2013 .

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML

M. Power, S. Nantel, K. Song, 2008, Bone Marrow Transplantation.

Bone Marrow Necrosis in Adult Acute Leukemia and Non-Hodgkin's Lymphoma

D. Forrest, T. Nevill, S. Couban, 2000, Leukemia & lymphoma.

Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.

M. Power, R. Broady, D. Hogge, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring

B. Leber, K. Rockwood, R. Wells, 2019, Leukemia.

Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy

A. Tantiworawit, M. Power, R. Broady, 2012, Leukemia & lymphoma.

Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort study

N. Murray, D. Hogge, M. Seftel, 2011, Bone Marrow Transplantation.

RETURN TO DURABLE DONOR HAEMATOPOIESIS AFTER BLAST PHASE RELAPSE OF CHRONIC MYELOID LEUKAEMIA FOLLOWING MARROW TRANSPLANTATION

K. Robinson, M. Barnett, W. Greer, 1992, British journal of haematology.

Autologous Stem Cell Transplant Outcome in Classic Hodgkin Lymphoma Patients in the Era of Post-Transplant Brentuximab Vedotin Consolidation

F. Kuchenbauer, M. Power, S. Nantel, 2021, Blood.

Predisposition to Myelodysplastic Syndrome with Deletion 5q Is Associated with TP53 Codon 72 Genotype

F. Solé, A. Karsan, M. Calasanz, 2010 .